Additional file 1 of Reductions in endometriosis-associated pain among women treated with elagolix are consistent across a range of baseline characteristics reflective of real-world patients

Abrao, Mauricio S., Surrey, Eric, Gordon, Keith, Snabes, Michael C., Wang, Hui, Ijacu, Horia, Taylor, Hugh S.
2021 · doi:10.6084/m9.figshare.14795093 · W6920961273
OA: green CC0
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This paper presents supplemental tables and figures detailing elagolix's consistent efficacy in reducing endometriosis-associated pain across various patient subgroups and its safety profile.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Additional file 1: Supplemental Table 1. Endometriosis Health Profile-30 at month 3 – pain; Supplemental Table 2. Endometriosis Health Profile-30 at month 3 – control and powerlessness; Supplemental Table 3. Endometriosis Health Profile-30 at month 3 – emotional well-being; Supplemental Table 4. Endometriosis Health Profile-30 at month 3 – social support; Supplemental Table 5. Endometriosis Health Profile-30 at Month 3 – self-image; Supplemental Table 6. Endometriosis Health Profile-30 at month 3 – sexual intercourse; Supplemental Table 7. Adverse events from integrated Elaris EM-I and Elaris EM-II by selected subgroup; Supplemental Figure 1. Co-primary endpoints at month 3 for integrated Elaris EM-I and II by baseline demographic subgroups; Supplemental Figure 2. Co-primary endpoints at month 3 for integrated Elaris EM-I and Elaris EM-II by disease severity subgroups; Supplemental Figure 3. Patient Global Impression of Change (PGIC) at month 3 for integrated Elaris EM-I and Elaris EM-II by baseline demographic subgroups; Supplemental Figure 4. Patient Global Impression of Change (PGIC) at month 3 for integrated Elaris EM-I and Elaris EM-II by disease severity subgroups.

My notes (saved in your browser only)

Outcome instruments

EHP-30

Condition tags

endometriosis

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (29)

Source provenance

openalex
last seen: 2026-05-11T08:33:45.119282+00:00
License: CC0 · commercial use OK